{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-016271","form_type":"8-K","ticker":"PETV","cik":"0001512922","company_name":"PetVivo Holdings, Inc.","filed_at":"2025-06-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.553521+00:00","generated_at":"2026-05-18T22:24:42.468028+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"PetVivo receives final $1M from $5M Series B Convertible Preferred Stock offering","bullets":["Received $1M from full exercise of Purchase Option, completing $5M equity financing.","Total of $5M raised via Series B Convertible Preferred Stock at $1 per share, convertible 1:1 into common stock.","Proceeds intended for commercialization of Spryng and PrecisePRP, clinical trials, and working capital.","Sale made under Section 4(a)(2) to accredited investor; shares are restricted.","Certificate of Designation filed on March 26, 2025; amendment on March 31, 2025 for Company Call Option."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-016271","json":"https://secwatch.observer/filing/0001641172-25-016271.json","markdown":"https://secwatch.observer/filing/0001641172-25-016271.md","text":"https://secwatch.observer/filing/0001641172-25-016271.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1512922/000164117225016271/0001641172-25-016271-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1512922/000164117225016271/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T22:24:42.468028+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}